Last reviewed · How we verify
CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS VACCINE
CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS VACCINE is a Biologic drug developed by Baylor College of Medicine. It is currently in Phase 1 development.
At a glance
| Generic name | CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS VACCINE |
|---|---|
| Sponsor | Baylor College of Medicine |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells (PHASE1)
- Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide (PHASE1)
- Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells (PHASE1)
- Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor Cells (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS VACCINE CI brief — competitive landscape report
- CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS VACCINE updates RSS · CI watch RSS
- Baylor College of Medicine portfolio CI
Frequently asked questions about CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS VACCINE
What is CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS VACCINE?
CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS VACCINE is a Biologic drug developed by Baylor College of Medicine.
Who makes CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS VACCINE?
CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS VACCINE is developed by Baylor College of Medicine (see full Baylor College of Medicine pipeline at /company/baylor-college-of-medicine).
What development phase is CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS VACCINE in?
CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS VACCINE is in Phase 1.